18207401

Source:http://linkedlifedata.com/resource/pubmed/id/18207401

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0013264, umls-concept:C0032074, umls-concept:C0079925, umls-concept:C0205390, umls-concept:C0205435, umls-concept:C0242262, umls-concept:C1512888, umls-concept:C1705822
pubmed:issue	3
pubmed:dateCreated	2008-4-9
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9111470
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Oligonucleotides, Antisense
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	0960-8966
pubmed:author	pubmed-author:BushbyKate DKD, pubmed-author:MuntoniFrancescoF, pubmed-author:van OmmenGertjanG
pubmed:issnType	Print
pubmed:volume	18
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	268-75
pubmed:meshHeading	pubmed-meshheading:18207401-Clinical Trials, Phase I as Topic, pubmed-meshheading:18207401-Clinical Trials, Phase II as Topic, pubmed-meshheading:18207401-Gene Therapy, pubmed-meshheading:18207401-Humans, pubmed-meshheading:18207401-Muscular Dystrophy, Duchenne, pubmed-meshheading:18207401-Oligonucleotides, Antisense
pubmed:year	2008
pubmed:articleTitle	149th ENMC International Workshop and 1st TREAT-NMD Workshop on: "planning phase i/ii clinical trials using systemically delivered antisense oligonucleotides in duchenne muscular dystrophy".
pubmed:affiliation	Dubowitz Neuromuscular Centre, Institute of Child Health & Great Ormond Street Hospital, 30 Guilford Street, London WC1N 1EH, UK. f.muntoni@ich.ucl.ac.uk
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Consensus Development Conference